Prescription drug · NDA
Paricalcitol NDC 0143-9625
Paricalcitol 2 ug/mL · Injection · Intravenous · West-Ward Pharmaceuticals Corp
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 0143-9625-25 | 0014396252500143962525 | 25 VIAL, SINGLE-DOSE in 1 CARTON (0143-9625-25) / 1 mL in 1 VIAL, SINGLE-DOSE (0143-9625-01)Marketed from Nov 18, 2014 |
How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Paricalcitol
- Generic name (nonproprietary)
- paricalcitol
- Active ingredients
- Paricalcitol — 2 ug/mL
- Dosage form
- Injection
- Route
- Intravenous
- Labeler
- West-Ward Pharmaceuticals CorpNDC labeler code 0143
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 205917
- Marketing start
- Listing expires
- Other FDA classes
- Cholecalciferol (Chemical structure)
- Identifiers
- Product ID 0143-9625_5830f342-11e2-4859-98c8-fdcfd89d606dSPL ID 5830f342-11e2-4859-98c8-fdcfd89d606dSPL set ID 4db985c4-3ba2-4967-898b-35af77f150deRxCUI 200321, 1736919, 1736931UNII 6702D36OG5
- Pharmacologic class
- Vitamin D3 Analog
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N400143962525followed by a unit qualifier and the quantityPackage 00143-9625-25. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Paricalcitol Injection is an active vitamin D 2 analogue indicated for the prevention and treatment of secondary hyperparathyroidism associated with chronic kidney disease (CKD) Stage 5. Paricalcitol Injection is an active vitamin D 2 analog indicated for the prevention and treatment of secondary hyperparathyroidism associated with chronic kidney disease Stage 5. ( 1 )
Excerpt only. Read the full label for complete information.
About NDC 0143-9625
- What is NDC 0143-9625?
- 0143-9625 is the product NDC for Paricalcitol, Paricalcitol 2 ug/mL injection, listed with the FDA by West-Ward Pharmaceuticals Corp. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Paricalcitol.
- What is the active ingredient?
- Paricalcitol.
- Who is the labeler?
- West-Ward Pharmaceuticals Corp, NDC labeler code 0143. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Paricalcitol?
- 33 other product NDCs are listed under this name. See all Paricalcitol NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Paricalcitol products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Paricalcitol | Paricalcitol 2 ug/mL | InjectionIntravenous | Eugia US LLC | 55150-212 | 55150-0212-01 |
| Paricalcitol | Paricalcitol 5 ug/mL | InjectionIntravenous | Eugia US LLC | 55150-213 | 55150-0213-01 |
| Paricalcitol | Paricalcitol 10 ug/2mL | InjectionIntravenous | Eugia US LLC | 55150-214 | 55150-0214-02 |
| Paricalcitol | Paricalcitol 10 ug/2mL | InjectionIntravenous | Eugia US LLC | 55150-215 | 55150-0215-02 |
| Paricalcitol | Paricalcitol 2 ug/mL | InjectionIntravenous | Amneal Pharmaceuticals LLC | 70121-1033 | 70121-1033-0570121-1033-07 |
| Paricalcitol | Paricalcitol 5 ug/mL | InjectionIntravenous | Amneal Pharmaceuticals LLC | 70121-1034 | 70121-1034-0570121-1034-07 |
| Paricalcitol | Paricalcitol 10 ug/2mL | InjectionIntravenous | Amneal Pharmaceuticals LLC | 70121-1035 | 70121-1035-0570121-1035-07 |
| Paricalcitol | Paricalcitol 10 ug/2mL | InjectionIntravenous | Amneal Pharmaceuticals LLC | 70121-1036 | 70121-1036-0570121-1036-07 |
| Paricalcitol | Paricalcitol 1 ug/1 | Capsule, Liquid filledOral | TIME CAP LABORATORIES, INC | 49483-687 | 49483-0687-03 |
| Paricalcitol | Paricalcitol 4 ug/1 | Capsule, Liquid filledOral | TIME CAP LABORATORIES, INC | 49483-689 | 49483-0689-03 |
Other NDCs under NDA 205917
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Paricalcitol | Paricalcitol 5 ug/mL | InjectionIntravenous | West-Ward Pharmaceuticals Corp | 0143-9596 |
| Paricalcitol | Paricalcitol 5 ug/mL | InjectionIntravenous | West-Ward Pharmaceuticals Corp | 0143-9624 |